Selective Modification of Streptozotocin at the C3 Position to Improve Its Bioactivity as Antibiotic and Reduce Its Cytotoxicity towards Insulin-Producing β Cells
- Supplementary File 1:
PDF-Document (PDF, 2258 KiB)
Zhang, J.; Yakovlieva, L.; de Haan, B.J.; de Vos, P.; Minnaard, A.J.; Witte, M.D.; Walvoort, M.T.C. Selective Modification of Streptozotocin at the C3 Position to Improve Its Bioactivity as Antibiotic and Reduce Its Cytotoxicity towards Insulin-Producing β Cells. Antibiotics 2020, 9, 182. https://doi.org/10.3390/antibiotics9040182
Zhang J, Yakovlieva L, de Haan BJ, de Vos P, Minnaard AJ, Witte MD, Walvoort MTC. Selective Modification of Streptozotocin at the C3 Position to Improve Its Bioactivity as Antibiotic and Reduce Its Cytotoxicity towards Insulin-Producing β Cells. Antibiotics. 2020; 9(4):182. https://doi.org/10.3390/antibiotics9040182
Chicago/Turabian StyleZhang, Ji, Liubov Yakovlieva, Bart J. de Haan, Paul de Vos, Adriaan J. Minnaard, Martin D. Witte, and Marthe T. C. Walvoort. 2020. "Selective Modification of Streptozotocin at the C3 Position to Improve Its Bioactivity as Antibiotic and Reduce Its Cytotoxicity towards Insulin-Producing β Cells" Antibiotics 9, no. 4: 182. https://doi.org/10.3390/antibiotics9040182